Nasdaq

Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Nasdaq

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

Stelo will be the first glucose biosensor in the US cleared for use without a prescription Indicated for use for people 18 years and older who are not using insulin therapy A small, wearable sensor ...
Monthly Prescribing Reference

Stelo OTC Wearable Glucose Biosensor Now Available

Credit: Dexcom. Stelo is an integrated CGM that continuously measures, records, analyzes, and displays glucose values in individuals 18 years of age and older who are not on insulin. Dexcom’s Stelo ...
MobiHealthNews

Dexcom over-the-counter Stelo Glucose Biosensor wins FDA clearance

An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA). Available without the need for a ...
FierceBiotech

Dexcom's Stelo, its first over-the-counter glucose monitor, hits the market

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now available ...
Monthly Prescribing Reference

Dexcom Stelo Biosensor Cleared as First OTC Continuous Glucose Monitor

Credit: Dexcom. The Dexcom Stelo Glucose Biosensor System is an integral CGM intended for individuals 18 years of age and older with or without diabetes who are not on insulin. The Food and Drug ...
CNET

FDA Clears First Over-the-Counter Continuous Glucose Monitor: What to Know About Biosensors

Stelo is meant for those with Type 2 diabetes as well as people who want more insight into their blood sugar levels. Here's how biosensors are growing in 2024. Jessica was a writer on the Wellness ...
Becker's Hospital Review

FDA clears 1st OTC glucose monitor

The FDA on March 5 cleared the Dexcom Stelo Glucose Biosensor System for use, making it the first continuous glucose monitoring device to be available over the counter. Stelo is intended for adults 18 ...
CNBC

Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
Benzinga.com

FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is ...